Deferasirox
Formulations: - Oral > Solid > dispersible tablet: 100 mg; 125 mg; 250 mg; 400 mg; 500 mg Oral > Solid > tablet: 90 mg; 180 mg; 360 mg Indications: - Other specified sickle cell disorders or other haemoglobinopathies - Thalassaemias Source: EML workbook import
MOQ: 1
Price on request
